Significant Association of Elevated Concentration of Plasma YKL-40 with Disease Severity in Patients With Pelvic Inflammatory Disease

Journal of Clinical Laboratory Analysis

Volumn 26, Issue 3, 2012, Pages 136-142

  Lee, Shu Hsin ^a,b   Lin, Ching Yi ^a,b   Wang, Po Hui ^a,b   Han, Chih Ping ^a,b   Yang, Shun Fa ^a,b   Chang, Jinghua Tsai ^a   Lee, Meng Chih ^a,b   Lin, Long Yau ^a,b   Lee, Maw Sheng ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CRP; Pelvic inflammatory disease; YKL 40

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PLASMA PROTEIN; UNCLASSIFIED DRUG; YKL 40 PROTEIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; PELVIC INFLAMMATORY DISEASE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUBOOVARIAN ABSCESS;

ADIPOKINES; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LECTINS; LEUKOCYTE COUNT; LOGISTIC MODELS; ODDS RATIO; PELVIC INFLAMMATORY DISEASE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84861464379     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21500     Document Type: Article

References (35)

1. Moore DE, Spadoni LR, Foy HM, et al. Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet 1982;2:574.
2. Wolner-Hanssen P. Silent pelvic inflammatory disease: Is it overstated. Obstet Gynecol 1995;86:321.
3. Renkema GH, Boot RG, Au FL, et al. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 1998;251:504-509.
4. Shackelton LM, Mann DM, Millis AJ. Identification of a 38-kDa heparin binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem 1995;270:13076-13083.
5. Badariotti F, Kypriotou M, Lelong C, et al. The phylogenetically conserved molluscan chitinase-like protein 1 (Cg-Clp1), homologue of human HC-gp39, stimulates proliferation and regulates synthesis of extracellular matrix components of mammalian chondrocytes. J Biol Chem 2006;281: 29583-29596.
6. Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 1997;43:221-225.
7. Johansen JS, Stoltenberg M, Hansen M, et al. Serum YKL-40 concentrations in patients with rheumatoid arthritis: Relation to disease activity. Rheumatology (Oxford) 1999;38:618-626.
8. Volck B, Price PA, Johansen JS, et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 1998;110:351-360.
9. Malinda KM, Ponce L, Kleinman HK, Shackelton LM, Millis AJ. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 1999;250:168-173.
10. Johansen JS, Olee T, Price PA, Hashimoto S, Ochs RL, Lotz M. Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum 2001;44:826-837.
11. Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev 2006;15:194-202.
12. Roslind A, Johansen JS. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 2009;511:159-184.
13. Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006;53:172-209.
14. Güngen G, Ardic F, Fιndikoǧlu G, Rota S. The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis. Rheumatol Int 2011. in press.
15. Syversen SW, Goll GL, van der Heijde D, et al. Cartilage and bone biomarkers in rheumatoid arthritis: Prediction of 10-year radiographic progression. J Rheumatol 2009;36:266-272.
16. Mizoguchi E, Mizoguchi A. Is the sugar always sweet in intestinal inflammation? Immunol Res 2007;37:47-60.
17. Kastrup J, Johansen JS, Winkel P, et al. High serum YKL-40 concentration in patients with stable coronary artery disease is associated with increased risk of myocardial infarction, cardiovascular death, and all-cause mortality. Eur Heart J 2009;30:1066-1072.
18. Letuve S, Kozhich A, Arouche N, et al. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol 2008;181:5167-5173.
19. Nielsen AR, Erikstrup C, Johansen JS, et al. Plasma YKL-40: A BMI-independent marker of type 2 diabetes. Diabetes 2008;57:3078-3082.
20. Johansen JS, Schultz NA, Jensen BV. Plasma YKL-40: A potential new cancer biomarker? Rev Future Oncol 2009;5:1065-1082.
21. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55(RR-11):1-94.
22. Bojesen SE, Johansen JS, Børge G. Nordestgaard BG. Plasma YKL-40 levels in healthy subjects from the general population. Clinica Chimica Acta 2011;412:709-712.
23. Renkema GH, Boot RG, Strijland A, et al. Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase. Eur J Biochem 1997;244:279-285.
24. Coffman FD. Chitinase 3-Like-1 (CHI3L1): A putative disease marker at the interface of proteomics and glycomics. Crit Rev Clin Lab Sci 2008;45:531-562.
25. Kzhyshkowska J, Gratchev A, Goerdt S. Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomark Insights 2007;2:128-146.
26. Malaguarnera L, Di Rosa M, Zambito AM, dell'Ombra N, Nicoletti F, Malaguarnera M. Chitotriosidase gene expression in Kupffer cells from patients with nonalcoholic fatty liver disease. Gut 2006;55:1313-1320.
27. Kawada M, Hachiya Y, Arihiro A, Mizoguchi E. Role of mammalian chitinases in inlammatory conditions. Keio J Med 2007;56:21-27.
28. Recklies AD, Ling H, White C, Bernier SM. Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J Biol Chem 2005;280:41213-41221.
29. Ling H, Recklies AD. The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumor necrosis factor-α. Biochem J 2004;380:651-659.
30. Zivanovic S, Rackov LP, Vojvodic D, Vucetic C. Human cartilage glycoprotein 39-Biomarker of joint damage in knee osteoarthritis. Int Orthop 2009;33:1165-1170.
31. Koutroubakis IE, Petinaki E, Dimoulios P. Increased serum levels of YKL-40 in patients with inflammatory bowel disease. Int J Colorectal Dis 2003;18:254-259.
32. Conrozier T, Carlier MC, Mathieu P, et al. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: A cross sectional study. Ann Rheum Dis 2000;59:828-831.
33. Hattori N, Oda S, Sadahiro T et al. YKL-40 identifie by proteomic analysis as a biomarker of sepsis. Shock 2009;32:393-400.
34. Živanović S, Rackov LP, Vojvodić D, Vučetić D. Human cartilage glycoprotein 39-Biomarker of joint damage in knee osteoarthritis. Int Orthop 2009;33:1165-1170.
35. Kronborg G, Østergaard C, Weis N, et al. Serum level of YKL-40 is elevated in patients with Streptococcus pneumonia bacteremia and is associated with the outcome of the disease. Scand J Infect Dis 2002;34, 323-326.